BIO.BE

Active

Public limited companyfounded 200322 yrs activeAvenue Georges Lemaitre 25, 6041 Charleroi, BelgiumKBO/BCE: BE 0861.738.595

Summary

BIO.BE has been active since 2003 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.7m and a net result of -€725,799. Equity is shrinking by ~6.1% per year across the filed fiscal years. Its solvency ranks better than 42% of 1246 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).

Risk analysis Watch Report Compare

BIO.BEActiveChecked score 56/100

Risk analysis Report Compare

Checked score

Score 2024

56 / 100

Fair

Every signal that weighs is under Signals.

Axes · tick = 2023

Profitability0=

Solvency71▼-19

Growth32=

Track record100

Bankruptcy probability, 12 months

0.1% Very low

0%0.5%1.5%4%10%≥ 25%

Credit up to €95,000 at 30 days acceptable

Liquidity tight (current ratio 1.09 against 2.18 in 2023; short-term debt: 37.9% and cash: 8.1% of total assets), and 53.8% of the assets are financed with debt.

Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Eight signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Lower-failure-rate sector

In this sector companies fail less often than the Belgian average.

Gazette · bankruptcies per sector, NACE 86

Relative position

BE, all sectors

reference

Human health activities (NACE 86)

about 87% fewer bankruptcies

← fewer bankruptcies more bankruptcies →

Long track record

A company with a long track record statistically fails less often than a young one.

KBO · incorporation date

Age against the risk zone

Multiple establishment units

Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.

KBO · establishment units

Lower-risk legal form

Companies with this legal form statistically fail less often than a BV.

KBO · legal form

Annual accounts: weaker financial profile

The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.

NBB · annual accounts 2024

Solvency, return and age of the figures

Solvency

46.2%

Return on assets

-19.6%

Age of the figures

21 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Persistent losses

Two consecutive loss-making years (2023 and 2024); equity is also lower. May indicate structural pressure on profitability.

NBB · annual accounts 2024

Net result per financial year

18192021222324

2018 to 2024 · latest year -€725,799

Latest accounts filed on time

The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 03-07-2025, 28 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

not confirmed

2024

28 d early

2023

23 d early

2022

35 d early

2021

39 d early

2020

24 d early

2019

31 d early

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

This company filed its last 6 accounts on average 30 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.

Checked, nothing found (1)

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

History

On 20 November 2003, BIO.BE was incorporated.¹ A capital increase in 2007 brought the capital to EUR 91,250.² Total assets went from EUR 4.9 million in 2018 to EUR 3.7 million in 2024 and headcount from 18.9 to 8.6 full-time equivalents.³

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2024, full schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

-€725,799▲ 24.9%

2023 · -€966,125

Working capital

€125,975▼ 84.8%

2023 · €828,691

Trend over the years

Chart Table

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before

favourable unfavourable

Line20202021202220232024

Operating result€561,638▼ 61.9%€273,414▼ 51.3%-€578,457-€980,534▼ 69.5%-€706,182▲ 28.0%

Net result€429,436▼ 63.2%€176,141▼ 59.0%-€612,631-€966,125▼ 57.7%-€725,799▲ 24.9%

Equity€3.9m▲ 12.1%€4.0m▲ 4.2%€3.4m▼ 15.4%€2.4m▼ 28.5%€1.7m▼ 30.1%

Total assets€5.9m▲ 0.1%€6.2m▲ 4.5%€5.0m▼ 19.0%€3.8m▼ 25.1%€3.7m▼ 1.5%

Debt€2.0m▼ 16.8%€2.2m▲ 4.9%€1.6m▼ 25.8%€1.3m▼ 17.7%€2.0m▲ 51.7%

Working capital€2.4m▲ 7.5%€2.3m▼ 4.2%€1.8m▼ 23.2%€828,691▼ 53.0%€125,975▼ 84.8%

Solvency65.4%▲ 7.0pp65.3%▼ 0.1pp68.2%▲ 2.9pp65.1%▼ 3.1pp46.2%▼ 18.9pp

Staff (FTE)23.2▲ 17.8%23.3▲ 0.4%21.6▼ 7.3%10.3▼ 52.3%8.6▼ 16.5%

above within below the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.

Result per fiscal year

Operating resultNet result

The operating result stays negative: a loss of €706,182 in 2024 against €980,534 in 2023; the loss shrinks.

Balance-sheet composition

2024 in colour, 2023 as the grey bar beneath

Assets €3.7m

58.7%

41.3%

Fixed assets €2.2m ▼ 2.5%

Current assets €1.5m ▼ 0.2%

Equity and liabilities €3.7m

46.2%

53.8%

Equity €1.7m ▼ 30.1%

Debt €2.0m ▲ 51.7%

Debt's share of the balance-sheet total rises from 34.9% to 53.8%. Equity is lower and debt is higher.

Key figures and ratios

2024 value · change against 2023

EBITDA

-€482,600▲

2023 · -€713,371

Cash flow

-€502,216▲

2023 · -€698,961

Current ratio

1.09▼

2023 · 2.18

Quick ratio

1.03▼

2023 · 2.04

Debt to equity

1.16▲

2023 · 0.54

ROE

-42.4%▼

2023 · -39.5%

ROA

-19.6%▲

2023 · -25.7%

Interest coverage

-12.92▲

2023 · -33.85

Debt ≤ 1 year

€1.4m▲

2023 · €704,375

Debt > 1 year

€474,148▼

2023 · €527,397

Staff costs

€820,146▼

2023 · €836,992

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 5,827 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 84% are still going.

Micro
20 years or older
solvency 30% or more
a loss of 10% of the balance sheet or more

1.5% went bankrupt

14% stopped otherwise

84% still going

A further 0.7% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group	Expected	Actual
1	0.2%	0.2%
2	0.3%	0.4%
3	0.5%	0.5%
4	0.6%	0.7%
5	0.8%	0.9%
6	1.2%	1.3%
7	1.5%	1.6%
8	1.7%	1.7%
9	2.7%	2.8%
10	5.3%	5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 5,827 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts

OverviewIncome statement Balance sheet Cash flow

Filed annual accounts As filed with the NBB · 2024 against 2023 · 57 lines

Balance sheet Code20232024

Assets

Total assets20/58€3.8m€3.7m▼

Fixed assets21/28€2.2m€2.2m▼

Intangible fixed assets21€116,276€95,382▼

Tangible fixed assets22/27€1.3m€1.1m▼

Land and buildings22€1.0m€947,398▼

Plant, machinery and equipment23€218,257€103,718▼

Furniture and vehicles24€25,964€18,651▼

Financial fixed assets28€846,853€1.0m▲

Current assets29/58€1.5m€1.5m▼

Stocks and contracts in progress3€94,844€77,184▼

Stocks30/36€94,844€77,184▼

Amounts receivable within one year40/41€815,838€1.0m▲

Trade receivables40€771,130€975,819▲

Other amounts receivable41€44,708€40,144▼

Cash at bank and in hand54/58€492,160€300,696▼

Deferred charges and accrued income490/1€130,223€135,710▲

Equity and liabilities

Total equity and liabilities10/49€3.8m€3.7m▼

Equity10/15€2.4m€1.7m▼

Contributions10/11€1.6m€1.6m=

Capital10€1.6m€1.6m=

Issued capital100€1.6m€1.6m=

Reserves13€159,125€159,125=

Non-distributable reserves130/1€159,125€159,125=

Legal reserve130€159,125€159,125=

Profit (loss) carried forward14€549,629-€176,171▼

Investment grants15€146,636€136,222▼

Amounts payable17/49€1.3m€2.0m▲

Amounts payable after more than one year17€527,397€474,148▼

Financial debts170/4€527,397€474,148▼

Amounts payable within one year42/48€704,375€1.4m▲

Current portion of amounts payable after more than one year42€52,014€53,249▲

Financial debts43€70,217€61,160▼

Credit institutions430/8€70,217€61,160▼

Trade debts44€435,074€133,408▼

Suppliers440/4€435,074€133,408▼

Taxes, remuneration and social security45€129,489€116,328▼

Taxes450/3€29,242€23,906▼

Remuneration and social security454/9€100,248€92,422▼

Other amounts payable47/48€17,582€1.0m▲

Accrued charges and deferred income492/3€80,000€112,128▲

Income statement Code20232024

Remuneration, social security and pensions62€836,992€820,146▼

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€267,163€223,583▼

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€67,167-€83,144▼

Other operating charges640/8€43,312€188,563▲

Gross operating margin9900€234,100€442,965▲

Operating profit (loss)9901-€980,534-€706,182▲

Financial income75/76B€19,510€17,726▼

Recurring financial income75€19,510€17,726▼

Financial charges65/66B€21,074€37,343▲

Recurring financial charges65€21,074€37,343▲

Profit (loss) for the period before taxes9903-€982,099-€725,799▲

Income taxes67/77-€15,974-

Profit (loss) for the period9904-€966,125-€725,799▲

Profit (loss) for the period to be appropriated9905-€966,125-€725,799▲

Appropriation of the result

Profit (loss) to be appropriated9906€549,629-€176,171▼

Profit (loss) brought forward from the previous period14P€1.5m€549,629▼

Social balance

Average headcount (FTE)908710.38.6▼

The notes to these accounts (16 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line	2020	2021	2022	2023	2024	Change
Remuneration, social security and pensions62	-	€1.6m	€1.6m	€836,992	€820,146	▼ 2.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630	€211,733	€252,069	€267,386	€267,163	€223,583	▼ 16.3%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4	-	€41,484	-€50,048	€67,167	-€83,144	▼ 224%
Other operating charges640/8	-	€137,062	€129,214	€43,312	€188,563	▲ 335%
Gross operating margin9900	€2.4m	€2.3m	€1.4m	€234,100	€442,965	▲ 89.2%
Operating profit (loss)9901	€561,638	€273,414	-€578,457	-€980,534	-€706,182	▲ 28.0%
Financial income75/76B	-	€13,402	€12,378	€19,510	€17,726	▼ 9.1%
Recurring financial income75	€13,617	€13,402	€12,378	€19,510	€17,726	▼ 9.1%
Financial charges65/66B	-	€32,386	€30,552	€21,074	€37,343	▲ 77.2%
Recurring financial charges65	€35,482	€32,386	€30,552	€21,074	€37,343	▲ 77.2%
Profit (loss) for the period before taxes9903	€539,772	€254,430	-€596,631	-€982,099	-€725,799	▲ 26.1%
Income taxes67/77	€110,336	€78,289	€16,000	-€15,974	-	-
Profit (loss) for the period9904	€429,436	€176,141	-€612,631	-€966,125	-€725,799	▲ 24.9%
Profit (loss) for the period to be appropriated9905	€429,436	€176,141	-€612,631	-€966,125	-€725,799	▲ 24.9%

Line	2020	2021	2022	2023	2024	Change
Assets
Total assets20/58	€5.9m	€6.2m	€5.0m	€3.8m	€3.7m	▼ 1.5%
Fixed assets21/28	€2.3m	€2.4m	€2.3m	€2.2m	€2.2m	▼ 2.5%
Intangible fixed assets21	€16,990	€16,106	€96,598	€116,276	€95,382	▼ 18.0%
Tangible fixed assets22/27	€1.6m	€1.7m	€1.5m	€1.3m	€1.1m	▼ 15.2%
Land and buildings22	-	€1.2m	€1.1m	€1.0m	€947,398	▼ 6.9%
Plant, machinery and equipment23	-	€543,368	€376,901	€218,257	€103,718	▼ 52.5%
Furniture and vehicles24	-	€2,613	€33,847	€25,964	€18,651	▼ 28.2%
Financial fixed assets28	€659,023	€659,023	€659,023	€846,853	€1.0m	▲ 18.7%
Current assets29/58	€3.6m	€3.8m	€2.8m	€1.5m	€1.5m	▼ 0.2%
Stocks and contracts in progress3	€207,588	€329,300	€257,141	€94,844	€77,184	▼ 18.6%
Stocks30/36	-	€329,300	€257,141	€94,844	€77,184	▼ 18.6%
Amounts receivable within one year40/41	€1.6m	€1.8m	€1.6m	€815,838	€1.0m	▲ 24.5%
Trade receivables40	-	€1.4m	€1.3m	€771,130	€975,819	▲ 26.5%
Other amounts receivable41	-	€418,279	€337,366	€44,708	€40,144	▼ 10.2%
Cash at bank and in hand54/58	€1.8m	€1.5m	€735,918	€492,160	€300,696	▼ 38.9%
Deferred charges and accrued income490/1	-	€194,242	€174,687	€130,223	€135,710	▲ 4.2%
Equity and liabilities
Total equity and liabilities10/49	€5.9m	€6.2m	€5.0m	€3.8m	€3.7m	▼ 1.5%
Equity10/15	€3.9m	€4.0m	€3.4m	€2.4m	€1.7m	▼ 30.1%
Contributions10/11	€1.6m	€1.6m	€1.6m	€1.6m	€1.6m	=
Capital10	-	€1.6m	€1.6m	€1.6m	€1.6m	=
Issued capital100	-	€1.6m	€1.6m	€1.6m	€1.6m	=
Reserves13	€159,125	€159,125	€159,125	€159,125	€159,125	=
Non-distributable reserves130/1	-	€159,125	€159,125	€159,125	€159,125	=
Legal reserve130	-	€159,125	€159,125	€159,125	€159,125	=
Profit (loss) carried forward14	€2.0m	€2.1m	€1.5m	€549,629	-€176,171	▼ 132%
Investment grants15	-	€167,463	€157,049	€146,636	€136,222	▼ 7.1%
Amounts payable17/49	€2.0m	€2.2m	€1.6m	€1.3m	€2.0m	▲ 51.7%
Amounts payable after more than one year17	€792,378	€630,217	€579,411	€527,397	€474,148	▼ 10.1%
Financial debts170/4	-	€630,217	€579,411	€527,397	€474,148	▼ 10.1%
Amounts payable within one year42/48	€1.2m	€1.5m	€999,717	€704,375	€1.4m	▲ 99.3%
Current portion of amounts payable after more than one year42	-	€162,161	€100,435	€52,014	€53,249	▲ 2.4%
Financial debts43	-	-	€31,553	€70,217	€61,160	▼ 12.9%
Credit institutions430/8	-	-	€31,553	€70,217	€61,160	▼ 12.9%
Trade debts44	€529,325	€997,821	€593,498	€435,074	€133,408	▼ 69.3%
Suppliers440/4	-	€997,821	€593,498	€435,074	€133,408	▼ 69.3%
Taxes, remuneration and social security45	-	€203,994	€256,650	€129,489	€116,328	▼ 10.2%
Taxes450/3	-	€43,202	€48,976	€29,242	€23,906	▼ 18.2%
Remuneration and social security454/9	-	€160,792	€207,674	€100,248	€92,422	▼ 7.8%
Other amounts payable47/48	-	€155,258	€17,582	€17,582	€1.0m	▲ 5,812%
Accrued charges and deferred income492/3	-	€789	€15,444	€80,000	€112,128	▲ 40.2%

Line	2020	2021	2022	2023	2024	Change
Profit (loss) for the period9904	€429,436	€176,141	-€612,631	-€966,125	-€725,799	▲ 24.9%
+ Depreciation and write-downs630	€211,733	€252,069	€267,386	€267,163	€223,583	▼ 16.3%
Operating cash flow (approximation)	€641,169	€428,210	-€345,245	-€698,961	-€502,216	▲ 28.1%
Investment in fixed assets (approximation)	-	-€330,129	-€140,539	-€237,837	-€168,964	▲ 29.0%
Change in cash	-	-€308,591	-€716,723	-€243,758	-€191,465	▲ 21.5%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

All 32Financial 2Gazette 20Filings 10

2025

19-12

State Gazette act Resignations: Pierre Coulie, Denis Dufrane and 3 others

Reappointments: Jean-François Ghidetti (director) and Gauthier Saelens (director) · Appointment: Bernard Willemart (director)12 facts ▸

General meeting, 13-06-2025
Director resignation, Pierre Coulie (director)
Director resignation, Denis Dufrane (director)
Director resignation, Michel Mahaux (director)
Director resignation, Didier Thiebaut (director)
Director resignation, François Fontaine (director)
Director reappointment, Jean-François Ghidetti (director)
Director reappointment, Gauthier Saelens (director)
Director appointment, Bernard Willemart (director)
Board composition, Jean-François Ghidetti (director)
Board composition, Gauthier Saelens (director)
Board composition, Bernard Willemart (director)

03-07

NBB filing Annual accounts filed

fiscal year 2024 · full schema

10-03

State Gazette act Appointments: RSM InterAudit, Céline Arnaud and Thierry Lejuste

6 facts ▸

General meeting, 28-06-2024
Auditor appointment, RSM InterAudit (statutory auditor)
Director appointment, Céline Arnaud (representative)
Director appointment, Thierry Lejuste (representative)
Board composition, Michel Mahaux (director)
Board composition, Jean-François Ghidetti (managing director)

2024

08-07

NBB filing Annual accounts filed

fiscal year 2023 · full schema

17-05

State Gazette act Purpose · Statutes amendment · Resignations & appointments

Purpose change · Capital · Power of attorney6 facts ▸

General meeting, 30-04-2024
Statutes amendment
Purpose change, La société a pour objet : - la mise en œuvre de tout moyen utile en vue de réaliser des tests qualitatifs et quantitatifs dans le domaine des biotechnologies, d…
Statutes amendment
Capital, €1.591.250
Power of attorney, Organe d'administration

2023

31-12

Financial Weakest financial yearnet -€966,125

Net result drops to -€966,125, the lowest in the series; recovery starts the following year.

26-06

NBB filing Annual accounts filed

fiscal year 2022 · full schema

2022

24-11

State Gazette act Resignations: P. Hilbert (director) and JM. Verhaegen (director)

Appointments: Denis Dufrane, Francois Fontaine and 5 others12 facts ▸

General meeting, 17-06-2022
Director resignation, P. Hilbert (director)
Director resignation, JM. Verhaegen (director)
Director appointment, Denis Dufrane (director)
Director appointment, Francois Fontaine (director)
Director appointment, Jean-François Ghidetti (director)
Director appointment, Jean-François Ghidetti (managing director)
Director appointment, Michel Mahaux (director)
Director appointment, Gauthier Saelens (director)
Director appointment, Didier Thiebaut (director)
Board meeting, 14-09-2022
Director appointment, Pierre Coulie (director)

22-06

NBB filing Annual accounts filed

fiscal year 2021 · full schema

2021

26-08

State Gazette act Reappointment: RSM InterAudit (statutory auditor)

1 fact ▸

Auditor reappointment, RSM InterAudit (statutory auditor)

07-07

NBB filing Annual accounts filed

fiscal year 2020 · full schema

2020

24-07

State Gazette act Resignation: Christian Gérard (director)

2 facts ▸

Board meeting, 25-10-2019
Director resignation, Christian Gérard (director)

Show earlier events

30-06

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2019

31-12

Financial Highest result since 2018net €1.2m ▲163%

Operating result €1.5m, net result €1.2m, both a record.

26-06

NBB filing Annual accounts filed

fiscal year 2018 · full schema

23-05

State Gazette act Resignations: Michel Petein (director) and Didier Thiebaut (director)

Appointments: Jean-François Ghidetti, GEFINCO and 5 others · Permanent representatives: Didier Thiebaut, JM. Verhaegen and Céline Aranud · Reappointments: Ch. Gérard, M. Mahaux and 2 others19 facts ▸

General meeting, 30-11-2018
Director resignation, Michel Petein (director)
Director resignation, Didier Thiebaut (director)
Director appointment, Jean-François Ghidetti (director)
Director appointment, GEFINCO (director)
Permanent representative, Didier Thiebaut
Director appointment, Pascale Hilbert (director)
Director reappointment, Ch. Gérard (director)
Director reappointment, M. Mahaux (director)
Director reappointment, G. Saelens (director)
Director reappointment, J. Verhaegen (director)
Permanent representative, JM. Verhaegen
+7 further facts in this act

2018

26-10

State Gazette act Resignations: Michel Pétein, Didier Thiebaut and 2 others

Appointments: Jean-François Ghidetti (director) and GEFINCO (director) · Permanent representative: Didier Thiebaut14 facts ▸

Board meeting, 14-09-2018
Director resignation, Michel Pétein (director)
Director resignation, Didier Thiebaut (director)
Director resignation, Philippe Pâques (director)
Director resignation, Philippe Lejeune (director)
Director appointment, Jean-François Ghidetti (director)
Director appointment, GEFINCO (director)
Permanent representative, Didier Thiebaut
Director appointment, Jean-François Ghidetti (managing director)
Board composition, Jean-François Ghidetti (managing director)
Board composition, Michel Mahaux (chair)
Board composition, Gauthier Saelens (director)
+2 further facts in this act

05-07

NBB filing Annual accounts filed

fiscal year 2017 · full schema

2017

12-06

NBB filing Annual accounts filed

fiscal year 2016 · full schema

23-05

State Gazette act Appointment: Didier THIEBAUT (director)

Reappointments: Gauthier Saelens, Michel Mahaux and 5 others · Permanent representative: J. Michel VERHAEGEN · Capital participation19 facts ▸

General meeting, 28-04-2017
Director appointment, Didier THIEBAUT (director)
Board composition, Gauthier Saelens (director)
Board composition, Michel Mahaux (director)
Board composition, Philippe Lejeune (director)
Board composition, Philippe Paque (director)
Board composition, Christian Gérard (director)
Board composition, Michel Pétein (director)
Board composition, SPRL J. Michel VERHAEGEN (director)
Board composition, Didier THIEBAUT (director)
Director reappointment, Gauthier Saelens (director)
Director reappointment, Michel Mahaux (director)
+7 further facts in this act

06-01

State Gazette act Reappointments: Philippe Paque (chair of the board) and Michel Petein (managing director)

3 facts ▸

Board meeting, 23-09-2016
Director reappointment, Philippe Paque (chair of the board)
Director reappointment, Michel Petein (managing director)

2016

03-10

State Gazette act Reappointments: Philippe Paque, Christian Gérard and 2 others

Resignations: J. Michel Verhaegen, Olivier Froment and Patrick Gérard · Appointment: SPRL J. Michel Verhaegen (director) · Permanent representative: J. Michel Verhaegen10 facts ▸

General meeting, 10-06-2016
Director reappointment, Philippe Paque (director)
Director reappointment, Christian Gérard (director)
Director reappointment, Philippe Lejeune (director)
Director reappointment, Michel Pétein (director)
Director resignation, J. Michel Verhaegen (director)
Director appointment, SPRL J. Michel Verhaegen (director)
Permanent representative, J. Michel Verhaegen
Director resignation, Olivier Froment (director)
Director resignation, Patrick Gérard (director)

16-08

State Gazette act Appointments: SPRL J. Verhaegen (director) and Michel Petein (managing director)

Permanent representative: J.Michel Verhaegen · Reappointments: Philippe Paque, Christian Gerard and Michel Petein · Resignations: Olivier Froment (director) and Patrick Gerard (director)9 facts ▸

General meeting, 10-06-2016
Director appointment, SPRL J. Verhaegen (director)
Permanent representative, J.Michel Verhaegen
Director reappointment, Philippe Paque (director)
Director reappointment, Christian Gerard (director)
Director reappointment, Michel Petein (director)
Director resignation, Olivier Froment (director)
Director resignation, Patrick Gerard (director)
Director appointment, Michel Petein (managing director)

16-06

NBB filing Annual accounts filed

fiscal year 2015 · full schema

03-03

State Gazette act Reappointments: Fallon, Chainiaux, Cludts & Garny, Michel Mahaux and Jean-Michel Verhaegen

Appointment: Gauthier Saelens (director)7 facts ▸

Board meeting, 05-06-2015
General meeting, 19-06-2015
Auditor reappointment, Fallon, Chainiaux, Cludts & Garny
General meeting, 20-11-2015
Director appointment, Gauthier Saelens (director)
Director reappointment, Michel Mahaux (director)
Director reappointment, Jean-Michel Verhaegen (director)

2015

18-06

State Gazette act Resignations & appointments

Power of attorney6 facts ▸

Board meeting, 09/06/2015
Power of attorney, Michel Petein
Power of attorney, Philippe Paque
Power of attorney, Gauthier Saelens
Power of attorney, Florence Bouffioux
Power of attorney, Christophe Delvoie

2013

12-12

State Gazette act Appointments: Michel Mahaux, Jean-Michel Verhaegen and Michel Petein

Reappointments: Philippe Paque, Olivier Froment and 4 others11 facts ▸

General meeting, 07-12-2012
Director appointment, Michel Mahaux (director)
Director appointment, Jean-Michel Verhaegen (director)
General meeting, 07-06-2013
Director reappointment, Philippe Paque (director)
Director reappointment, Olivier Froment (director)
Director reappointment, Christian Gerard (director)
Director reappointment, Patrick Gerard (director)
Director reappointment, Philippe Lejeune (director)
Director reappointment, Michel Petein (director)
Director appointment, Michel Petein (managing director)

03-12

State Gazette act Appointments: Michel Mahaux, Jean-Michel Verhaegen and Michel Petein

Reappointments: Philippe Paque, Olivier Froment and 4 others11 facts ▸

General meeting, 07-12-2012
Director appointment, Michel Mahaux (director)
Director appointment, Jean-Michel Verhaegen (director)
General meeting, 07-06-2013
Director reappointment, Philippe Paque (director)
Director reappointment, Olivier Froment (director)
Director reappointment, Christian Gerard (director)
Director reappointment, Patrick Gerard (director)
Director reappointment, Philippe Lejeune (director)
Director reappointment, Michel Petein (director)
Director appointment, Michel Petein (managing director)

2012

07-11

State Gazette act Reappointment: Fallon, Chainaux, Cludts & Garny (company auditor)

2 facts ▸

General meeting, 15-06-2012
Auditor reappointment, Fallon, Chainaux, Cludts & Garny (company auditor)

2011

24-03

State Gazette act Reappointments: Paque Philippe, Petein Michel and 4 others

13 facts ▸

General meeting, 29-06-2010
Director reappointment, Paque Philippe (director)
Director reappointment, Petein Michel (director)
Director reappointment, Froment Olivier (director)
Director reappointment, Gerard Christian (director)
Director reappointment, Gerard Patrick (director)
Director reappointment, Lejeune Philippe (director)
Board composition, Paque Philippe (chair)
Board composition, Petein Michel (managing director)
Board composition, Froment Olivier (director)
Board composition, Gerard Christian (director)
Board composition, Gerard Patrick (director)
+1 further facts in this act

14-01

State Gazette act Reappointment: Fallon, Chainaux, Cludts & Garny (company auditor)

Resignation: Isabelle Montaigne (directrice générale) · Appointment: Michel Petein (directeur général)8 facts ▸

General meeting, 26-06-2009
Auditor reappointment, Fallon, Chainaux, Cludts & Garny (company auditor)
Board meeting, 22-04-2010
Director resignation, Isabelle Montaigne (directrice générale)
Board meeting, 10-09-2010
Director appointment, Michel Petein (directeur général)
Board composition, Michel Petein (directeur général administrateur)
Board composition, Olivier Froment (director)

2007

15-01

State Gazette act Appointment: Etienne NOEL (director)

Capital increase · Share issue · Capital8 facts ▸

General meeting, 21-12-2006
Capital increase, €29.250
Share issue, 15, 29250
Capital, €91.250
Statutes amendment
Statutes amendment
Director appointment, Etienne NOEL (director)
Preemption waiver, augmentation de capital de 29250 EUR

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

20 of 21 acts read

About the unread acts

Of the 21 Belgian State Gazette acts we know for this company, 20 have been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors

under verification, last change in 2025

This board is reconstructed from a single act (25160533). A Gazette act generally publishes only CHANGES, not a full roll call, so directors unchanged since then may be missing here. The KBO register holds the complete list of function holders.

Board 3

Gauthier SAELENS

Director · since 19-06-2015

Current

Jean-François Ghidetti

Director · since 14-09-2018

Current

Bernard Willemart

Director · since 13-06-2025

Current

8 not recently confirmed

Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.

Philippe Paque

Chair of the board · Director · since 01-06-2010

Not recently confirmed

Etienne NOËL

Director · since 21-12-2006

Not recently confirmed

SPRL J. Verhaegen

Director · since 10-06-2016 · Legal entity · perm. rep.: J.Michel Verhaegen

Not recently confirmed

G. Saelens

Director · since 30-11-2018

Not recently confirmed

Pascale Hilbert

Director · since 30-11-2018

Not recently confirmed

Ch. Gérard

Director

Not recently confirmed

J. Verhaegen

Director · Legal entity · perm. rep.: JM. Verhaegen

Not recently confirmed

SPRL J. Michel VERHAEGEN

Director · Legal entity · perm. rep.: J. Michel VERHAEGEN

Not recently confirmed

Day-to-day management 1

Jean-François Ghidetti

Managing director · since 14-09-2018

Current

Permanent representatives 2

Céline Arnaud

Representative · since 28-06-2024

Current

Thierry Lejuste

Representative · since 28-06-2024

Current

2 not recently confirmed

Still in office according to the acts, but no act of the last six years confirms the mandate. It has often ended since, in an act we have not read.

J. Michel VERHAEGEN

Permanent representative · for SPRL J. Michel VERHAEGEN

Not recently confirmed

JM. Verhaegen

Permanent representative · for J. Verhaegen

Not recently confirmed

Statutory auditor 1

RSM INTERAUDIT

Statutory auditor · since 30-11-2018

Current

Other functions 1

Florence Bouffioux

Directrice financière · since 30-11-2018

Not recently confirmed

Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ. See the function holders in the CBE →

Not every act has been read: a resignation may be missing here

1 of this company's 21 Belgian State Gazette acts has not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.

Location & real-estate footprint

Registered office, Charleroi · 2 establishment units since 2003

seat establishment approximate 1 of 2 establishment units on the map

Ground area

5,399 m²

Parcel 52028B0318/00G002, Wallonia. Linked by address, not a title deed.

2 establishment units

Bio.Be S.A

Rue Louis Breguet 1, 6041 CharleroiNACE 73100

since 20032.214.938.283

BIO.BE

Avenue Georges Lemaitre 25, 6041 CharleroiOther technical testing and analysis

since 20032.234.696.688

1 parcel

Wallonia 1 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
52028B0318/00G002	Wallonia	5,399 m²	-	-

Linked by address, not proof of ownership

Good to know

1 of 1 parcel with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Mandate history

32 people since 2006, 15 in office

All 32 In office 15 Ended 17

Board
Day-to-day management
Permanent representative
Statutory auditor
Other function
not recently confirmed
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
Gauthier SAELENS	Director, from 19-06-2015 to date
Jean-François Ghidetti	Director, from 14-09-2018 to date Managing director, from 14-09-2018 to date
Bernard Willemart	Director, from 13-06-2025 to date
Céline Arnaud	Representative, from 28-06-2024 to date
Thierry Lejuste	Representative, from 28-06-2024 to date
RSM INTERAUDIT	Statutory auditor, from 30-11-2018 to date
Etienne NOËL	Director, from 21-12-2006 not ended, last confirmed 15-01-2007
Philippe Paque	Director, already before 01-06-2010 not ended, last confirmed 23-05-2017 Chair of the board, already before 06-01-2017 not ended, last confirmed 06-01-2017
SPRL J. Verhaegen	Director, from 10-06-2016 not ended, last confirmed 16-08-2016
SPRL J. Michel VERHAEGEN	Director, already before 23-05-2017 not ended, last confirmed 23-05-2017
G. Saelens	Director, from 30-11-2018 not ended, last confirmed 23-05-2019
Pascale Hilbert	Director, from 30-11-2018 not ended, last confirmed 23-05-2019
Ch. Gérard	Director, already before 23-05-2019 not ended, last confirmed 23-05-2019
J. Verhaegen	Director, already before 23-05-2019 not ended, last confirmed 23-05-2019
Florence Bouffioux	Directrice financière, from 30-11-2018 not ended, last confirmed 23-05-2019
Didier THIEBAUT	Director, from 28-04-2017 to 17-10-2018 Director, until 30-11-2018 Director, from 17-06-2022 to 13-06-2025
DUFRANE Denis Pol	Director, from 14-09-2022 to 13-06-2025
M. MAHAUX	Director, from 07-12-2012 to 13-06-2025 Chair, from 30-11-2018 ended, last mentioned 23-05-2019
Prof. Pierre Coulie	Director, from 14-09-2022 to 13-06-2025
FONTAINE François	Director, from 14-09-2022 to 31-12-2024
JM. Verhaegen	Director, until 17-06-2022
P. Hilbert	Director, until 17-06-2022
Christian Gérard	Director, already before 01-06-2010 to 31-12-2019
Fallon, Chainiaux, Cludts & Garny	Auditor, from 19-06-2015 to 30-11-2018
M. PETEIN	Directeur général, from 26-06-2009 ended, last mentioned 06-01-2017 Director, already before 01-06-2010 to 17-10-2018 Director, until 30-11-2018
Philippe Lejeune	Director, already before 01-06-2010 to 17-10-2018
Philippe Paques	Director, until 17-10-2018
Jean-Michel Verhaegen	Director, from 07-12-2012 to 10-06-2016
Olivier Froment	Director, already before 01-06-2010 to 10-06-2016 Director, until 10-06-2016
Patrick Gerard	Director, already before 01-06-2010 to 10-06-2016 Director, until 10-06-2016
Fallon, Chainaux, Cludts & Garny	Company auditor, from 26-06-2009 to 19-06-2015
Isabelle Montaigne	Directrice générale, until 26-06-2009

Show all 32 people Show the first 12See the board, name and seat on a given date →

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 31-12-2024 list no shareholders, and no other source names one.

Holdings 1

OncoDNA

Sourceown accounts 2024
Equity €5.8mResult -€10.4m

5.05%

According to the 2024 annual accounts of BIO.BE and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

25 connected companies

Depth

Shared directors

This company Company Director Shareholding +N: links not shown yet Click a node to look further, drag to arrange, scroll to zoom.

Linked via shared directors

MercurHosp

via Gauthier SAELENS · Director

→

RSM INTERAUDIT

via Thierry Lejuste · Permanent representative

→

UNESSA

via Gauthier SAELENS · Director

→

CENTRE CHAPELLE-AUX-CHAMPS

via Gauthier SAELENS · Director

former→

Show 21 more companies with a shared director

GRAND HOPITAL DE CHARLEROI

via Gauthier SAELENS · Directeur général

former→

Institut de Pathologie et de Génétique

via Gauthier SAELENS and Bernard Willemart

former→

Service de Santé mentale @Le Méridien@

via Gauthier SAELENS · Director

former→

THIERRY LEJUSTE

via Thierry Lejuste · Permanent representative

former→

Virvolti

via Thierry Lejuste · Co signataire du mandat

former→

Advanced Fire Technologies

Shared director

→

ASSOCIATION BELGE CONTRE LE CANCER

Shared director

→

Association de la Parfaite Union de Mons

Shared director

→

Centre d'Action Laique

Shared director

→

FEDERATION BELGE CONTRE LE CANCER-BELGISCHE FEDERATIE TEGEN KANKER-BELGISCHE FÖDERATION GEGEN KREKS-BELGIAN FEDERATION AGAINST CANCER

Shared director

→

FEDERATION REGIONALE DES ASSOCIATIONS DE TELEMATIQUE MEDICALE

Shared director

→

FLUXYS

Shared director

→

Fondation Charcot-Vaincre la sclérose en plaques

Shared director

→

FONDATION CONTRE LE CANCER

Shared director

→

Fund+

Shared director

→

J.MICHEL VERHAEGEN

Shared director

→

LE PORT DE BRUXELLES

Shared director

→

Promotion de l'Emploi à Schaerbeek

Shared director

→

SOCIETE FEDERALE DE PARTICIPATIONS ET D'INVESTISSEMENT

Shared director

→

Theracell Consulting

Shared director

→

Unie van socialprofitondernemingen

Shared director

→

Ownership & control

1 board mandate

Board mandates of this companythis company sits on their board1

OncoDNA

1 location

Capital and shareholders

Shareholders according to the acts

After the capital increase act of 15-01-2007 ↗

Hygiène publique en Hainaut (BE 0417.029.229)

The Belgian State Gazette names shareholders only when an act mentions them; the share register itself is not published.

Capital over the years

17-05-2024 Capital stated in the act · 1,591,250 EUR · 214 shares
15-01-2007 Capital increase of 29,250 EUR · to 91,250 EUR · 15 new shares

Recognitions · licences · registrations

Legal Entity Identifier

6994004NV3YGQR7G6N95

no longer live in the LEI register

Similar companies · same sector, comparable size

EVIPA

BE 0546.730.996

Beveren-Kruibeke-Zwijndrecht · Eq €1,728,052

RADIOLOGIE DR. JAGER TJEERD

BE 0479.421.411

Aalst · Eq €1,682,358

DOKTER EVERT MUNGHEN

BE 0474.829.549

Lokeren · Eq €1,672,595

Dokter VAN MULDERS N., HUISARTS

BE 0463.085.819

Aalst · Eq €1,665,422

DIAGNOSECENTRUM VOORKEMPEN

BE 0457.169.413

Zoersel · Eq €1,757,481

Of 699 companies in sector 86910 we hold annual accounts for 521. 362 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification

Legal formPublic limited company

Founded20-11-2003

Fiscal year end31-12

Trade name FR Seqalis

Activities, NACEBEL 2025

86910Medical imaging and medical laboratories

71209Other technical testing and analysis

72101Research and development on biotechnology

Contact

Website www.seqalis.comCharleroi

E-invoicing

Reachable via Peppol

Peppol ID 0208:0861738595

Also 9925:BE0861738595

Registered 17-10-2025

Scores and ratios are computed by Checked and are not a credit decision.